Bioventus Inc Capital Reinvestment Ratio

Latest as of June 2026: 0.05x

Bioventus Inc capital reinvestment ratio. Bioventus Inc (BVS) has a Capital Reinvestment Ratio of 0.05x as of June 2026, meaning it reinvests 0% of its operating cash flow ($19.87 Million) in capital expenditures ($960.00K). Check Bioventus Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.05x
Capex / Operating Cash Flow

Operating Cash Flow

$19.87 Million
USD

Capital Expenditures

$960.00K
USD

Data as of

Jun 2026
Most recent filing

Capital Reinvestment Ratio of Bioventus Inc (2013–2025)

Capital reinvestment ratio of Bioventus Inc from 2013 to 2025. This chart tracks Bioventus Inc's Capital Reinvestment Ratio across 10 annual periods. Also explore net asset growth rate of Bioventus Inc to track the company's year-over-year net asset growth rate.

Bioventus Inc Capital Reinvestment Ratio by Year (2013–2025)

Bioventus Inc capital reinvestment ratio by year from 2013 to 2025. For the full cash flow conversion analysis, see cash efficiency ratio of Bioventus Inc.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 0.03x $73.98 Million $2.56 Million ▲ +33.6%
2024 0.03x $38.80 Million $1.01 Million ▼ -94.6%
2023 0.48x $15.34 Million $7.36 Million ▲ +49.7%
2021 0.32x $22.99 Million $7.37 Million ▲ +11.3%
2020 0.29x $71.80 Million $20.67 Million ▲ +40.5%
2019 0.20x $40.71 Million $8.34 Million ▲ +52.8%
2018 0.13x $45.19 Million $6.06 Million ▼ -65.9%
2015 0.39x $18.92 Million $7.44 Million ▼ -71.5%
2014 1.38x $15.11 Million $20.83 Million ▼ -40.4%
2013 2.31x $2.75 Million $6.36 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow